Search This Blog

Thursday, August 1, 2019

Agios Pharmaceuticals EPS misses by $0.15, misses on revenue

Agios Pharmaceuticals (NASDAQ:AGIO): Q2 GAAP EPS of -$1.87 misses by $0.15.
Revenue of $26.22M (-35.1% Y/Y) misses by $0.83M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)